Navigation Links
Quorum Review IRB and ConsentSolutions Form Strategic Alliance
Date:9/5/2013

Seattle, WA (PRWEB) September 05, 2013

Quorum Review, IRB, the industry leader in central IRB services, announces a strategic alliance with Consent Solutions, a developer of internet-based multimedia systems for informed consent in the clinical trials industry. Through the alliance, Quorum Review and Consent Solutions combine and leverage their extensive experience and knowledge to provide an improved informed consent experience.

The alliance demonstrates Quorum Review’s and Consent Solutions’ commitment to enhance the research process, especially as the healthcare industry increasingly adopts electronic data systems. Working together, Quorum Review and Consent Solutions provide an intuitive and effective electronic consent option that meets industry and IRB regulations and standards.

“Quorum Review is excited to work closely with an eConsent provider who understands our industry so well,” says Cami Gearhart, JD, CEO of Quorum Review. “We believe our customers will benefit from this alliance as the healthcare and human research industry move further toward electronic data management.”

"We feel so privileged to be able to work closely with Quorum,” states Susan G. Brink, DrPH, President and CEO of Consent Solutions. “The relationship will allow us to optimize workflows and fine-tune the processes behind electronic consent from the perspective of a leading-edge IRB. Our partnership offers the potential of bringing all of the benefits of eConsent to patients and industry on a much shorter timeline."

About Quorum Review

Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.

For more information about Quorum Review, visit http://www.quorumreview.com.

About Consent Solutions

Consent Solutions has been spearheading the development and adoption of electronic consent in the clinical space since 2003. The result of extensive and ongoing research with patients, sponsors, regulatory bodies, CROs and IRBs, the Consent Solutions platform, SecureConsent, takes a patient-centered approach that is supported by video and electronic multimedia to facilitate and enhance patient comprehension. Backed by tightly controlled administrative procedures and controls, granular tracking, sophisticated version control and multi-lingual support, the SecureConsent ecosystem tackles many of the problems of paper-based consenting.

For more information about Consent Solutions, visit http://www.consentsolutions.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11087659.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quorum Review IRB Board Chair Appointed to SACHRP
2. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems
3. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
4. Unigenes 2011 Year in Review - Key Elements in Place to Address Debt in 2012
5. FDAs Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012
6. Nonprofit Consortium Publishes Review of Skullcap Adulteration
7. Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.
8. Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2012
9. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Second Quarter 2012 Financials
10. Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012
11. Alzheimers Therapeutics Reviewed by NeuroPerspective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... Ca (PRWEB) , ... May 25, 2017 , ... ... truly understanding the full process behind each occurrence. Live cell imaging using fluorescence ... this webinar, the use of automated fluorescence microscopy methods will be discussed, from ...
(Date:5/24/2017)... (PRWEB) , ... May 23, 2017 , ... Federal funding ... well as an enabler of life-saving medical and other vital technologies — deserves continued ... They joined others in the scientific community today in responding to the President’s budget ...
(Date:5/23/2017)... , ... May 23, 2017 ... ... an unlimited source of human cardiovascular cells for research and the development ... makes it possible to generate large numbers of cardiomyocytes (hPSC-CMs). Due to ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... applications, has announced a facility expansion to accommodate its rapid growth. , The ... new workspace and renovation of the existing areas. The expansion includes, a state-of-the-art ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
Breaking Biology News(10 mins):